The China OTC Pharmaceuticals Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the China OTC Pharmaceuticals Market is estimated to be USD 18.24 Billion and predicted to rise to USD 24.77 billion with a CAGR of 6.32%. The market is segmented by formulation, Product type, distribution channels. China OTC Pharmaceuticals market accounts to a share of 33.4 % of total Asia-Pacific OTC market. Accessibility, Affordability, Faith, and Authorization are the four aspects that value the OTC drugs that provide consumers and healthcare system of a nation.
The factors that are driving the growth of the market are growing healthcare expenditure internally, increased urbanization, aging population, improvement and government investment for better healthcare. The factors that are restraining the growth of the market are Competition in china is key to a fierce among the Major companies, which are seeking to penetrate the market, Intricate knowledge of the region and pricing will decide who gets a head, whereas new comers face increasing risks, the government has implemented an ambivalent attitude towards OTC Products and is unwilling to promote self-medication
The China OTC Pharmaceutical Market is broadly categorized by Formulation type - Tablets, Liquids, Ointments, Sprays, by Product type - Cough and cold Flu drugs, Analgesics, Dermatologics, Gastrointestinal Drugs, Antiseptics, Anti-allergy drugs, Smoking Cessation Aids, Vitamins and Minerals, Ophthalmics, sleep aids, Weightloss/diet drugs and others(Ear Drops & Diuretics). By distribution channels - Pharmacies/Drug Stores, Supermarkets/Hypermarkets, convenience stores, others (online drug stores).
Some of the major players influencing the OTC Pharmaceutical market in china are - Harbin Pharmaceutical Group, Jiangzhong Pharmaceutical Co., Ltd, Renhe (Group) Development Co., Ltd, Tianjin SK&F Pharmaceutical Co., Ltd, Wyeth Pharmaceutical, Xi'an-Janssen Pharmaceutical, Yangtze River Pharmaceutical Group, Yunnan Baiyao Group Co., Ltd, Zhejiang Conba Pharmaceutical Co., Ltd, GlaxoSmithKline, Bayer Beijing, Novartis.
Browse through the full report at “http://www.marketdataforecast.com/market-reports/china-over-the-counter-drugs-market-799/” and checkout our recent reports in the Pharmaceuticals category at “http://www.marketdataforecast.com/research-reports/healthcare/pharmaceuticals-1/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.